Very High Risk Neuroblastoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Very High Risk Neuroblastoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedPhase 2

NCT03165292

Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction

The main objective is to evaluate the efficacy of two intensified consolidation strategies in very-high risk neuroblastoma (VHR-NBL) patients in terms of event-…

Austria, France, Italy34 participantsStarted 2018-10-01

Treatment: mIBG, Topotecan